Skip to content

Dison Pharma: what changed

BE 0640.801.992NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€76,391
2024 · €71,903+€4,488
Equity
€301,711
2024 · €230,732+€70,979
Cash
€248,721
2024 · €196,892+€51,830
Balance sheet total
€638,498
2024 · €629,255+€9,243

Largest movements

2024 to 2025
Assets
  • Cash +€51,830

    up €51,830 (+26.3%), from €196,892 to €248,721

    mainly Net result for the year (+€76,391) and Depreciation (+€33,218)

  • Intangible fixed assets -€19,542

    no longer reported in 2025; in 2024 it stood at €19,542

  • Tangible fixed assets -€10,844

    down €10,844 (-5.1%), from €210,782 to €199,938

    of which Land and buildings: -€7,257

  • Receivables within one year -€9,935

    down €9,935 (-9.6%), from €103,641 to €93,706

    of which Trade receivables: -€5,554

Equity and liabilities
  • Reserves +€70,500

    up €70,500 (+50.0%), from €140,860 to €211,360

  • Current portion of long-term debt -€27,574

    down €27,574 (-66.2%), from €41,643 to €14,069

  • Trade debts -€19,687

    down €19,687 (-31.0%), from €63,592 to €43,905

  • Debts after one year -€14,069

    down €14,069 (-9.2%), from €153,532 to €139,463

Income statement
  • Taxes +€10,727

    up €10,727 (+52.5%), from €20,428 to €31,156

  • Staff costs -€5,880

    down €5,880 (-4.7%), from €124,017 to €118,137

  • Depreciation -€4,732

    down €4,732 (-12.5%), from €37,951 to €33,218

  • Gross operating margin +€3,522

    up €3,522 (+1.3%), from €266,969 to €270,491

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €71,903
Gross operating margin +€3,522
Staff costs +€5,880
Depreciation +€4,732
Other operating charges -€90
Other operating items -€45
Financial income +€83
Financial charges +€1,133
Taxes -€10,727
Result 2025 €76,391
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€101,718
Investment -€2,833
Financing -€47,055
Cash 2024 €196,892
Net result for the year +€76,391
Depreciation +€33,218
Stocks and contracts +€1,907
Receivables within one year +€9,935
Deferred charges and accrued income +€358
Trade debts -€19,687
Tax, wage and social debts +€396
Other debts -€261
Accrued charges and deferred income -€541
Investment in fixed assets (net) -€2,833
Debts after one year -€14,069
Current portion of long-term debt -€27,574
Contributions, distributions and other -€5,412
Cash 2025 €248,721
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €629,255 €638,498 +€9,243 +1.5%
Fixed assets 21/28 €230,323 €199,938 -€30,385 -13.2%
Intangible fixed assets 21 €19,542 - -€19,542
Tangible fixed assets 22/27 €210,782 €199,938 -€10,844 -5.1%
Land and buildings 22 €183,474 €176,217 -€7,257 -4.0%
Plant, machinery and equipment 23 €22,357 €19,735 -€2,622 -11.7%
Furniture and vehicles 24 €4,951 €3,986 -€965 -19.5%
Current assets 29/58 €398,931 €438,560 +€39,629 +9.9%
Stocks and contracts in progress 3 €92,133 €90,226 -€1,907 -2.1%
Stocks 30/36 €92,133 €90,226 -€1,907 -2.1%
Amounts receivable within one year 40/41 €103,641 €93,706 -€9,935 -9.6%
Trade receivables 40 €98,658 €93,104 -€5,554 -5.6%
Other amounts receivable 41 €4,983 €602 -€4,381 -87.9%
Cash at bank and in hand 54/58 €196,892 €248,721 +€51,830 +26.3%
Deferred charges and accrued income 490/1 €6,265 €5,907 -€358 -5.7%
Total equity and liabilities 10/49 €629,255 €638,498 +€9,243 +1.5%
Equity 10/15 €230,732 €301,711 +€70,979 +30.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €140,860 €211,360 +€70,500 +50.0%
Distributable reserves 133 €140,860 €211,360 +€70,500 +50.0%
Profit (loss) carried forward 14 €71,272 €71,751 +€479 +0.7%
Amounts payable 17/49 €398,522 €336,786 -€61,736 -15.5%
Amounts payable after more than one year 17 €153,532 €139,463 -€14,069 -9.2%
Financial debts 170/4 €153,532 €139,463 -€14,069 -9.2%
Amounts payable within one year 42/48 €237,182 €190,056 -€47,125 -19.9%
Current portion of amounts payable after more than one year 42 €41,643 €14,069 -€27,574 -66.2%
Trade debts 44 €63,592 €43,905 -€19,687 -31.0%
Suppliers 440/4 €63,592 €43,905 -€19,687 -31.0%
Taxes, remuneration and social security 45 €36,017 €36,413 +€396 +1.1%
Taxes 450/3 €15,391 €21,131 +€5,740 +37.3%
Remuneration and social security 454/9 €20,626 €15,282 -€5,344 -25.9%
Other amounts payable 47/48 €95,930 €95,670 -€261 -0.3%
Accrued charges and deferred income 492/3 €7,808 €7,267 -€541 -6.9%
Remuneration, social security and pensions 62 €124,017 €118,137 -€5,880 -4.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,951 €33,218 -€4,732 -12.5%
Other operating charges 640/8 €2,667 €2,757 +€90 +3.4%
Non-recurring operating charges 66A - €45 +€45
Gross operating margin 9900 €266,969 €270,491 +€3,522 +1.3%
Operating profit (loss) 9901 €102,334 €116,333 +€13,999 +13.7%
Financial income 75/76B €2,326 €2,410 +€83 +3.6%
Recurring financial income 75 €2,326 €2,410 +€83 +3.6%
Financial charges 65/66B €12,329 €11,196 -€1,133 -9.2%
Recurring financial charges 65 €12,329 €11,196 -€1,133 -9.2%
Profit (loss) for the period before taxes 9903 €92,331 €107,547 +€15,216 +16.5%
Income taxes 67/77 €20,428 €31,156 +€10,727 +52.5%
Profit (loss) for the period 9904 €71,903 €76,391 +€4,488 +6.2%
Profit (loss) for the period to be appropriated 9905 €71,903 €76,391 +€4,488 +6.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€414,459 to €519,901

Midpoint €458,393 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €301,711
Capitalised earnings €527,207 to €738,090
Indication €414,459 to €519,901

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€301,711
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€301,711

Capitalised earnings

net result for the year (9904)
2025
€76,391
excluding non-recurring income and charges
€76,436
2024
€71,903
2023
€73,088
2022
€71,253
excluding non-recurring income and charges
€71,683
2021
€74,083
Average result, excluding non-recurring income and charges
€73,809
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€527,207 / €615,075 / €738,090

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.